Skip to main content

Table 3 T-test analysis of cytokine levels between patients and controls

From: Cytokine levels reflect tic symptoms more prominently during mild phases

Cytokine

Patients

Controls

p value

Pro-inflammatory

   

 GM-CSF

0.13 ± 0.44

0.01 ± 0.05

0.111

 IFN-α2

4.09 ± 6.98

6.57 ± 17.05

0.433

 IFN-γ

0.49 ± 0.52

0.72 ± 0.68

0.112

 IL-1β

3.54 ± 2.57

4.81 ± 3.02

0.070

 IL-2

0.24 ± 0.16

0.36 ± 0.49

0.153

 IL-5

1.26 ± 0.96

1.69 ± 1.27

0.117

 IL-6

0.37 ± 0.24

0.38 ± 0.15

0.898

 IL-8

12.65 ± 6.77

13.18 ± 5.56

0.729

 IL-12 p40

14.79 ± 9.93

28.21 ± 59.35

0.192

 IL-12 p70

0.91 ± 0.43

0.99 ± 0.23

0.318

 IL-17a

1.63 ± 6.15

0.14 ± 0.17

0.160

 TNF-α

7.18 ± 10.14

5.40 ± 1.78

0.339

Anti-inflammatory

   

 IL-1ra

235.21 ± 158.40

219.95 ± 105.13

0.651

 IL-4

0.39 ± 0.23

0.46 ± 0.20

0.204

 IL-10

4.98 ± 4.11

6.09 ± 5.09

0.337

 IL-13

5.67 ± 8.60

7.76 ± 9.63

0.356

  1. *p < 0.05
  2. GM-CSF granulocyte-macrophage colony-stimulating factor; IFN interferon, IL interleukin, TNF tumor necrosis factor